Snowflake Surges 30 After Earnings Beat and 6 Billion AWS Commitment Irelands Datacentre Electricity Surge Drives Household Costs Report Warns DMG Blockchain Q2 2026 Earnings Miss Triggers Stock Decline TikToks Revenue Surge How Creators and Businesses Build Income on the Platform eHealth EHTH May See Increased Target as Operational Improvements Gain Traction Kyle Busch TwoTime NASCAR Champion Dies at 41 from Sepsis and Pneumonia Lantheus Holdings LNTH Q1 2026 Earnings EPS Surges Past Estimates as Radiopharmaceutical Momentum Continues WFRD Q1 2026 Earnings Strong EPS Beat but Stock Declines Amdocs DOX Q1 2026 Earnings Slight EPS Miss Meets Modest Market Optimism CURR Q3 2025 Earnings Strong EPS Surprise as Profitability Emerges Revenue Details Not Disclosed ABCB Q1 2026 Earnings EPS Surpasses Estimates Amidst Stable Operations COLL Q1 2026 Earnings EPS Beats Estimates by 843 as Collegium Posts 176 Luda Technology Group LUD Surges 395 as Shares Test Key Resistance Near 469 TON Strategy TONX Slips 926 as Bearish Momentum Builds Key Support Holds City Holding CHCO Posts Modest Gain as Stock Holds Above Key Support Thor Industries THO Rises 184 as RV Maker Holds Above Support Tests Key Resistance Advanced Drainage Systems WMS Pulls Back Amid ProfitTaking Key Support Levels in Focus Streaming Platforms Gear Up for Weekend Content Drop Netflix Hulu Prime Video Apple TV and More Unveil New Releases EFXT Q1 2026 Earnings Earnings Surge Past Estimates by 65 Blackrock MuniHoldings Fund Inc MHD Holds Near Support Amid Modest Decline NSIT Q1 2026 Earnings Strong EPS Beat Drives Stock Up 31 ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Continued Clinical Progress Okta Inc OKTA Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Revenue Ambiguity UBCP Q4 2022 Earnings Solid EPS Performance Drives Positive Stock Movement Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline BILI Q1 2026 Earnings EPS Surpasses Estimates by 135 Stock Gains Solid Biosciences Q1 2026 Earnings WiderthanExpected Loss as Biotech Advances Pipeline